دورية أكاديمية
Clinical Value of the Quantitative Flow Ratio to Predict Long-term Target Vessel Failure in Patients with In-stent Restenosis after Drug-coated Balloon Angioplasty.
| العنوان: | Clinical Value of the Quantitative Flow Ratio to Predict Long-term Target Vessel Failure in Patients with In-stent Restenosis after Drug-coated Balloon Angioplasty. |
|---|---|
| المؤلفون: | Wu XQ; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China., Li LB; Department of Cardiology, The Second Hospital of Jilin University, Jilin, 130000, China., You W; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China., Wu ZM; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China., Zhao L; Department of Cardiology, The Second Hospital of Jilin University, Jilin, 130000, China., Wang ZH; Department of Cardiology, The Second Hospital of Jilin University, Jilin, 130000, China., Meng PN; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China., Liu B; Department of Cardiology, The Second Hospital of Jilin University, Jilin, 130000, China. liubin3333@vip.sina.com., Ye F; Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China. njsdxn2017@163.com. |
| المصدر: | Current medical science [Curr Med Sci] 2024 Jun; Vol. 44 (3), pp. 561-567. Date of Electronic Publication: 2024 May 29. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Huazhong University of Science and Technology Country of Publication: China NLM ID: 101729993 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2523-899X (Electronic) Linking ISSN: 2523899X NLM ISO Abbreviation: Curr Med Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Wuhan : Huazhong University of Science and Technology, [2018]- |
| مواضيع طبية MeSH: | Coronary Restenosis*/etiology , Coronary Restenosis*/diagnostic imaging , Angioplasty, Balloon, Coronary*/methods , Angioplasty, Balloon, Coronary*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Drug-Eluting Stents ; Follow-Up Studies ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/methods ; Coronary Vessels/diagnostic imaging ; Coronary Vessels/physiopathology ; Coronary Vessels/surgery |
| مستخلص: | Objective: The study sought to investigate the clinical predictive value of quantitative flow ratio (QFR) for the long-term target vessel failure (TVF) outcome in patients with in-stent restenosis (ISR) by using drug-coated balloon (DCB) treatment after a long-term follow-up. Methods: This was a retrospective study. A total of 186 patients who underwent DCB angioplasty for ISR in two hospitals from March 2014 to September 2019 were enrolled. The QFR of the entire target vessel was measured offline. The primary endpoint was TVF, including target vessel-cardiac death (TV-CD), target vessel-myocardial infarction (TV-MI), and clinically driven-target vessel revascularization (CD-TVR). Results: The follow-up time was 3.09±1.53 years, and 50 patients had TVF. The QFR immediately after percutaneous coronary intervention (PCI) was significantly lower in the TVF group than in the no-TVF group. Multivariable Cox regression analysis indicated that the QFR immediately after PCI was an excellent predictor for TVF after the long-term follow-up [hazard ratio (HR): 5.15×10 -5 (6.13×10 -8 -0.043); P<0.01]. Receiver-operating characteristic (ROC) curve analysis demonstrated that the optimal cut-off value of the QFR immediately after PCI for predicting the long-term TVF was 0.925 (area under the curve: 0.886, 95% confidence interval: 0.834-0.938; sensitivity: 83.40%, specificity: 88.00; P<0.01). In addition, QFR≤0.925 post-PCI was strongly correlated with the TVF, including TV-MI and CD-TVR (P<0.01). Conclusion: The QFR immediately after PCI showed a high predictive value of TVF after a long-term follow-up in ISR patients who underwent DCB angioplasty. A lower QFR immediately after PCI was associated with a worse TVF outcome. (© 2024. Huazhong University of Science and Technology.) |
| References: | Stefanini GG, Byrne RA, Windecker S, et al. State of the art: coronary artery stents–past, present and future. EuroIntervention, 2017,13(6):706–716. (PMID: 10.4244/EIJ-D-17-0055728844032) Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol, 2020,17(1):37–51. (PMID: 10.1038/s41569-019-0234-x31346257) Nicolais CV, Lakhter V, Virk HUH, et al. Therapeutic Options for In-Stent Restenosis. Curr Cardiol Rep, 2018,20(2):7. (PMID: 10.1007/s11886-018-0952-429435779) Goel SS, Dilip Gajulapalli R, Athappan G, et al. Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis. Catheter Cardiovasc Interv, 2016,87(6):1080–1091. (PMID: 10.1002/ccd.2615126613637) Lee MS, Banka G. In-stent Restenosis. Interv Cardiol Clin, 2016,5(2):211–220. (PMID: 28582205) Liu S, Worme M, Yanagawa B, et al. Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis. J Invasive Cardiol, 2018,30(10):360–366. (PMID: 30108189) Peng N, Liu W, Li Z, et al. Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials. Cardiovasc Ther, 2020,2020:1042329. (PMID: 10.1155/2020/1042329324112987204349) Aoki J, Tanabe K. Mechanisms of drug-eluting stent restenosis. Cardiovasc Interv Ther, 2021,36(1):23–29. (PMID: 10.1007/s12928-020-00734-733222019) Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J, 2019,40(2):87–165. (PMID: 10.1093/eurheartj/ehy39430165437) Xu B, Tu S, Qiao S, et al. Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis. J Am Coll Cardiol, 2017,70(25):3077–3087. (PMID: 10.1016/j.jacc.2017.10.03529101020) Cortes C, Carrasco-Moraleja M, Aparisi A, et al. Quantitative flow ratio-Meta-analysis and systematic review. Catheter Cardiovasc Interv, 2021,97(5):807–814. (PMID: 10.1002/ccd.2885732196932) Tang J, Hou H, Chu J, et al. Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis. Clin Cardiol, 2021,44(7):978–986. (PMID: 10.1002/clc.23630340096728259159) Cai X, Tian F, Jing J, et al. Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis. Catheter Cardiovasc Interv, 2021,97(Suppl 2):1048–1054. (PMID: 10.1002/ccd.2964033742738) van der Heijden LC, Kok MM, Lam MK, et al. Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial. Clin Res Cardiol, 2016,105(3):206–215. (PMID: 10.1007/s00392-015-0907-326329584) Biscaglia S, Tebaldi M, Brugaletta S, et al. Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study. JACC Cardiovasc Interv, 2019,12(20):2079–2088. (PMID: 10.1016/j.jcin.2019.06.00331563688) Kogame N, Takahashi K, Tomaniak M, et al. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease. JACC Cardiovasc Interv, 2019,12(20):2064–2075. (PMID: 10.1016/j.jcin.2019.08.00931563682) Alfonso F, Perez-Vizcayno MJ, Cardenas A, et al. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial. J Am Coll Cardiol, 2015,66(1):23–33. (PMID: 10.1016/j.jacc.2015.04.06326139054) Foy AJ, Dhruva SS, Peterson B, et al. Coronary Computed Tomography Angiography vs Functional Stress Testing for Patients With Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis. JAMA Intern Med, 2017,177(11):1623–1631. (PMID: 10.1001/jamainternmed.2017.4772289731015710269) Shlofmitz E, Torguson R, Zhang C, et al. Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study). Int J Cardiol, 2021,340:17–21. (PMID: 10.1016/j.ijcard.2021.08.00334371029) Secco GG, Foin N, Viceconte N, et al. Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. EuroIntervention, 2011,7(7):828–834. (PMID: 10.4244/EIJV7I7A13022082578) Raber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention, 2018,14(6):656–677. (PMID: 10.4244/EIJY18M06_0129939149) Cassese S, Xu B, Habara S, et al. Incidence and predictors of reCurrent restenosis after drug-coated balloon Angioplasty for Restenosis of a drUg-eluting Stent: The ICARUS Cooperation. Rev Esp Cardiol (Engl Ed), 2018,71(8):620–627. (PMID: 10.1016/j.recesp.2017.07.03428916429) |
| فهرسة مساهمة: | Keywords: in-stent restenosis; percutaneous coronary intervention; quantitative flow ratio; target vessel failure |
| تواريخ الأحداث: | Date Created: 20240529 Date Completed: 20240627 Latest Revision: 20240627 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1007/s11596-024-2876-0 |
| PMID: | 38809380 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 2523-899X |
|---|---|
| DOI: | 10.1007/s11596-024-2876-0 |